Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-5,357
Closed -$220K – 4730
2016
Q1
$215K Buy
5,357
+5,297
+8,828% +$213K ﹤0.01% 3073
2015
Q4
$3K Sell
60
-2,267
-97% -$104K ﹤0.01% 4628
2015
Q3
$110K Buy
+2,327
New +$118K ﹤0.01% 4241
2014
Q3
– Sell
-3,419
Closed -$184K – 5120
2014
Q2
$182K Sell
3,419
-9,222
-73% -$489K ﹤0.01% 3304
2014
Q1
$661K Buy
12,641
+3,806
+43% +$193K 0.01% 2271
2013
Q4
$474K Buy
8,835
+292
+3% +$15.1K ﹤0.01% 2711
2013
Q3
$433K Buy
8,543
+2,543
+42% +$129K ﹤0.01% 2941
2013
Q2
$309K Buy
+6,000
New +$320K ﹤0.01% 3237

Other funds holding SNY

PEAK6 Group's SNY Position: Q2 2016 in Review

PEAK6 Group sold out of Sanofi (SNY) in Q2 2016, closing a stake of 5,357 shares — an estimated $220K sold.

PEAK6 Group first reported a position in SNY in Q2 2013 and held it in 8 quarters. The position peaked at $661K in Q1 2014. 450 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

  • PEAK6 Group reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 5,357 Sanofi shares in Q2 2016, an estimated $220K.
  • PEAK6 Group first reported a position in Sanofi in Q2 2013 and held it in 8 quarters.
  • PEAK6 Group's Sanofi position peaked at $661K in Q1 2014.
  • 450 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.